PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases

2024-04-01
(Press-News.org)

ROCHESTER, Minn. — Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. 



The new technique, detailed in a preclinical study published in Nature Biomedical Engineering, involves combining chimeric antigen receptors (CAR) with mesenchymal stromal cells (MSC), resulting in engineered stem cells known as CAR-MSCs. 



“The pioneering approach shows potential in targeting inflammatory disease sites more precisely and improving immunosuppression and healing outcomes,” says Saad Kenderian, M.B., Ch.B., a principal investigator and hematologist at Mayo Clinic. “We’re planning to study interventions that minimize the need for long-term medications for autoimmune diseases.”





The combination approach centers on mesenchymal stromal cells, which are found in various tissues in the body, including bone marrow, fat tissue and umbilical cord blood. These cells have the unique ability to transform into several specific types of cells such as bone cells, cartilage cells and fat cells. 



Mesenchymal stromal cells are known for calming down the immune system, controlling inflammation and promoting immune tolerance to prevent the body's own tissues from being attacked.



Within this CAR-MSCs framework, mesenchymal stromal cells are engineered with chimeric antigen receptors, which are molecular tools engineered to recognize specific disease-related markers.



Chimeric antigen receptors have three crucial functions: 1) Target and attach to specific markers on diseased cells. 2) Act as an anchor to ensure the chimeric antigen receptors stay connected to the target. 3) Initiate signaling to activate a robust immune response.



While mesenchymal stromal cells have been extensively studied in isolation in autoimmune contexts, their efficacy has fallen short. The combined CAR-MSC therapeutic strategy tackles two key challenges: Mesenchymal stromal cells by themselves have difficulty calming down the strong immune reactions in autoimmune conditions, and they struggle to travel to and attach to the areas of inflammation.



Engineering mesenchymal stromal cells with chimeric antigen receptors shows potential in enhancing their ability to target specific cells or markers and improve their therapeutic impact.



How CAR-MSCs target inflammation

For the study, Dr. Kenderian and his team developed CAR-MSCs to specifically target a protein linked to a condition called graft-versus-host disease, as well as inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease.



Graft-versus-host disease occurs when cells from a donor attack the tissues of the person receiving them, typically following a bone marrow or stem cell transplant.



In mouse models, upon stimulation by the specific protein they were designed to target, CAR-MSCs showed improved ability to go to the inflamed area, have better control of inflammation and improve outcomes and survival. This was mediated by a change in the genetic signature of CAR-MSCs, the proteins they released and receptor expression.



Dr. Kenderian emphasizes that these preliminary findings set the stage for future applications of this technology, paving the way to enhance the therapy's versatility to address various diseases across the autoimmune spectrum.



This study builds upon a series of previously published studies on CAR-T therapy led by Dr. Kenderian and his collaborators at Mayo Clinic's Center for Individualized Medicine, Center for Regenerative Biotherapeutics and the Mayo Clinic Comprehensive Cancer Center. Dr. Kenderian is also investigating ways to make CAR-T cell therapy more accessible to patients through on-site biomanufacturing at Mayo Clinic's campuses in Rochester, Minnesota and Jacksonville, Florida.



Review the study for a complete list of authors, disclosures and funding.



###



About Mayo Clinic  
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and to providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. 



END


ELSE PRESS RELEASES FROM THIS DATE:

We’ve had bird evolution all wrong

We’ve had bird evolution all wrong
2024-04-01
An enormous meteor spelled doom for most dinosaurs 65 million years ago. But not all. In the aftermath of the extinction event, birds — technically dinosaurs themselves — flourished.  Scientists have spent centuries trying to organize and sort some 10,000 species of birds into one clear family tree to understand how the last surviving dinosaurs filled the skies. Cheap DNA sequencing should have made this simple, as it has for countless other species. But birds were prepared to deceive us. In a pair of new research papers ...

New method reveals hidden activity of life below ground

New method reveals hidden activity of life below ground
2024-04-01
A team of scientists led by researchers at Bigelow Laboratory for Ocean Sciences have developed an innovative method to link the genetics and function of individual microbes living without oxygen deep below Earth’s surface. Measuring both of these attributes — and, more importantly, linking them together — has long been a challenge in microbiology but is critical for understanding the role of microbial communities in global processes like the carbon cycle.  The new approach, developed at Bigelow Laboratory’s Single Cell Genomics Center, enabled researchers to discover that one species of sulfate-consuming ...

New antibiotic class effective against multidrug-resistant bacteria

2024-04-01
Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The new antibiotic class is described in an article in the scientific journal PNAS. Antibiotics are the foundation of modern medicine and over the last century have dramatically improved the lives of people around the world. Nowadays we tend to take antibiotics for granted and rely heavily on them to treat or prevent ...

A new family tree revises our understanding of bird evolution

A new family tree revises our understanding of bird evolution
2024-04-01
Birds are the only dinosaur lineage that survived until today. About 66 million years ago at the Cretaceous–Paleogene (K–Pg) boundary, a mass extinction event destroyed all non-avian dinosaurs, providing an opportunity for birds to diversify rapidly and occupy a wide range of ecological niches. Neoaves, a diverse group comprising approximately 95% of all bird species today, emerged from this radiation. From the towering condors of the Andes to the diminutive hummingbirds flitting through tropical forests, Neoaves encompass a stunning ...

Computational tools fuel reconstruction of new and improved bird family tree

Computational tools fuel reconstruction of new and improved bird family tree
2024-04-01
An international team of scientists has built the largest and most detailed bird family tree to date—an intricate chart delineating 93 million years of evolutionary relationships between 363 bird species, representing 92% of all bird families. The advance was made possible in large part thanks to cutting-edge computational methods developed by engineers at the University of California San Diego, combined with the university’s state-of-the-art supercomputing resources at the San Diego Supercomputer Center. These technologies have enabled researchers to analyze vast amounts of genomic data with high accuracy and speed, ...

New USF study: Research reveals language barriers limit effectiveness of cybersecurity resources

New USF study: Research reveals language barriers limit effectiveness of cybersecurity resources
2024-04-01
TAMPA, Fla. (April 1, 2024) – The idea for Fawn Ngo’s latest research came from a television interview. Ngo, a University of South Florida criminologist, had spoken with a Vietnamese language network in California about her interest in better understanding how people become victims of cybercrime. Afterward, she began receiving phone calls from viewers recounting their own experiences of victimization. “Some of the stories were unfortunate and heartbreaking,” said Ngo, an associate professor in the USF College of Behavioral and Community Sciences. “They made me wonder about the availability ...

CU researchers awarded grant to develop genetic risk score for thyroid cancer

2024-04-01
Researchers at the University of Colorado School of Medicine are hopeful new research could prevent up to 130,000 unneeded fine-needle aspiration (FNA) biopsies of thyroid nodules and subsequent surgeries each year in the United States by better understanding the genetic risk associated with thyroid cancer. Through an R21 grant from the National Institutes of Health, Nikita Pozdeyev, MD, assistant professor of biomedical informatics, Chris Gignoux, PhD, professor of biomedical informatics, and Bryan Haugen, MD, professor of medicine and head of the Division of Endocrinology, Metabolism, and Diabetes, will study new strategies that could pave the way ...

NIST researchers use cellphone compass to measure tiny concentrations of compounds important for human health

NIST researchers use cellphone compass to measure tiny concentrations of compounds important for human health
2024-04-01
Nearly every modern cellphone has a built-in compass, or magnetometer, that detects the direction of Earth’s magnetic field, providing critical information for navigation. Now a team of researchers at the National Institute of Standards and Technology (NIST) has developed a technique that uses an ordinary cellphone magnetometer for an entirely different purpose — to measure the concentration of glucose, a marker for diabetes, to high accuracy. The same technique, which uses the magnetometer in conjunction with magnetic materials designed ...

Frisch to conduct research on healing the traumatized body in second temple Judaism

2024-04-01
Frisch To Conduct Research On Healing The Traumatized Body In Second Temple Judaism                                                                                                                                  Alexandria ...

Reducing late-night alcohol sales curbed all violent crimes by 23% annually in a Baltimore neighborhood

2024-04-01
FOR IMMEDIATE RELEASE Monday, April 1, 2024 Contact: Jillian McKoy, jpmckoy@bu.edu Michael Saunders, msaunder@bu.edu ## Reducing Late-Night Alcohol Sales Curbed All Violent Crimes by 23% Annually in a Baltimore Neighborhood A new study found that reducing alcohol hours of sale for bars and taverns in a Baltimore, Md. neighborhood also reduced homicides by 51 percent within the first month and by 40 percent annually, pointing to possible opportunities for other cities to address excessive drinking and crime. Simply reducing the hours during which alcohol may be purchased can significantly reduce violent crime, ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Mayo Clinic scientists pioneer immunotherapy technique for autoimmune diseases